F
François Dabis
Researcher at University of Bordeaux
Publications - 584
Citations - 28654
François Dabis is an academic researcher from University of Bordeaux. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 85, co-authored 571 publications receiving 27110 citations. Previous affiliations of François Dabis include Université Félix Houphouët-Boigny & Université Bordeaux Segalen.
Papers
More filters
Journal ArticleDOI
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis
Marie-Louise Newell,Hoosen M. Coovadia,Marjo Cortina-Borja,Nigel Rollins,Philippe Gaillard,François Dabis +5 more
TL;DR: Findings highlight the necessity for timely antiretroviral care for support for HIV-infected women and children in developing countries, and for assessment of prophylactic programmes to prevent MTCT, including child mortality and infection averted.
Journal ArticleDOI
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
Caroline A. Sabin,Signe Westring Worm,Rainer Weber,Peter Reiss,Wafaa El-Sadr,François Dabis,Stéphane De Wit,Mathew M.G. Law,Antonella d'Arminio Monforte,Nina Friis-Møller,Ole Kirk,Christian Pradier,Ian V. D. Weller,Andrew N. Phillips,Jens D Lundgren +14 more
TL;DR: There exists an increased risk of myocardial infarction in patients exposed to abacavir and didanosine within the preceding 6 months and the excess risk does not seem to be explained by underlying established cardiovascular risk factors and was not present beyond 6 months after drug cessation.
Journal ArticleDOI
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Jonathan A C Sterne,Margaret T May,Dominique Costagliola,Frank de Wolf,Andrew N. Phillips,Ross Harris,Michele Jonsson Funk,Ronald B. Geskus,John Gill,François Dabis,José M. Miró,Amy C. Justice,Bruno Ledergerber,Gerd Fätkenheuer,Robert S. Hogg,Antonella d'Arminio Monforte,Michael S. Saag,Colette Smith,Schlomo Staszewski,Matthias Egger,Stephen R. Cole +20 more
TL;DR: In this article, the CD4 cell count at which combination antiretroviral therapy should be started is examined in the absence of randomised trials in prospective cohort studies, and the effect of deferred initiation of combination therapy with immediate initiation on rates of AIDS and death, and on death alone, in adjacent CD4 cells ranges of width 100 cells per microL.
Journal ArticleDOI
6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial
François Dabis,Philippe Msellati,Nicolas Meda,Christiane Welffens-Ekra,Bruno You,Olivier Manigart,Valériane Leroy,Arlette Simonon,M Cartoux,Patrice Combe,A Ouangre,R. Ramon,Odette Ky-Zerbo,Crépin Montcho,Roger Salamon,Christine Rouzioux,Philippe Van de Perre,Laurent Mandelbrot +17 more
TL;DR: A short course of oral zidovudine given during the peripartum period is well accepted and well tolerated, and provides a 38% reduction in early vertical transmission of HIV-1 infection despite breastfeeding.
Journal ArticleDOI
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
A Babiker,S Darby,Daniela De Angelis,D Kwart,Kholoud Porter,Beral,JH Darbyshire,Nicholas E. Day,Noel Gill,Roel A. Coutinho,Maria Prins,B van Benthem,François Dabis,C Marimoutou,I Ruiz,J M Tusell,C Altisent,B Evatt,Harold W. Jaffe,Ole Kirk,C.B. Pedersen,P Rosenberg,James J. Goedert,Robert J. Biggar,Mads Melbye,R Brettie,A Downs,Osamah Hamouda,Giota Touloumi,Anastasia Karafoulidou,Olga Katsarou,S Donfield,E Gomperts,M Hilgartner,K Hoots,E Schoenbaum,R Zangerle,J Del Amo,P Pezzotti,G. Rezza,S Hutchinson,Sheila M. Gore,L Kingsley,L Schrager,S Melnick,Beryl A. Koblin,Anne Eskild,Johan N. Bruun,Mette Sannes,Barry Evans,Alessandro Cozzi Lepri,CA Sabin,Susan Buchbinder,Eric Vittinghoff,A Moss,D Osmond,W Winkelstein,David J. Goldberg,Faroudy Boufassa,Laurence Meyer,Matthias Egger,Patrick Francioli,Martin Rickenbach,David A. Cooper,B Tindall,T Sharkey,Jeanette Vizzard,John M. Kaldor,P Cunningham,Philippe Vanhems,J Learmont,Farewell,O Berglund,J Mosley,E Operskalski,M.A.M.C. van den Berg,David S. Metzger,D Tobin,George E. Woody,J Rusnak,C Hendrix,R Garner,C Hawkes,P Renzullo,F Garland,D Ewart,P Giangrande,C Lee,Andrew N. Phillips,R Spooner,J Wilde,Mark Winter,AM Johnson,JI Lorenzo,M Schechter,Collaborative Grp Aids Incubation +95 more
TL;DR: Before widespread use of highly-active antiretroviral therapy (before 1996), time since seroconversion and age at serconversion were the major determinants of survival and development of AIDS in Europe, North America, and Australia.